Abridge’s New Funding Set to Reduce ‘Pajama Time’ for Doctors

With its recent $150 million Series C funding and a valuation of $850 million, Abridge is positioned at the forefront of AI-powered healthcare solutions, potentially becoming the "Duolingo of healthcare" in terms of widespread impact and adoption.
When was the last time any of us took a medical book to a hospital? Loads of medical records from previous consultations and every bill. Dr Shivdev Rao, felt that rather than saving lives of patients as a cardiologist he was wasting much more time in writing his notes. To help more patients and doctors he introduced Abridge, a healthtech firm located in downtown Pittsburgh which provides a solution in the form of an app that captures and summarises patient-doctor discussions.  Founded in 2018, Shiv Rao, a cardiologist with a flair for innovation, pitched a startup idea to Andy Weissman, a general partner at Union Square Ventures (USV), describing it as a blend of SoundCloud and RapGenius for medicine. While the comparison to music and lyrics platforms initially amused Weissman, Rao
Subscribe or log in to Continue Reading

Uncompromising innovation. Timeless influence. Your support powers the future of independent tech journalism.

Already have an account? Sign In.

📣 Want to advertise in AIM Media House? Book here >

Picture of Anshika Mathews
Anshika Mathews
Anshika is the Senior Content Strategist for AIM Research. She holds a keen interest in technology and related policy-making and its impact on society. She can be reached at anshika.mathews@aimresearch.co
25 July 2025 | 583 Park Avenue, New York
The Biggest Exclusive Gathering of CDOs & AI Leaders In United States

Subscribe to our Newsletter: AIM Research’s most stimulating intellectual contributions on matters molding the future of AI and Data.